Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 586 AL 600

Nanoparticle Mediated Gene Therapy: A Trailblazer Armament to Fight CNS Disorders

Annu, Rehman S, Nabi B, Sartaj A, Md S, Sahoo PK, Baboota S, Ali J.

Curr Med Chem. 2023;30(3):304-315. doi: 10.2174/0929867329666220105122318.

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Koerich S, Parreira GM, de Almeida DL, Vieira RP, de Oliveira ACP.

Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903.

Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Gupta D, Edison P.

Ageing Res Rev. 2023 Aug;89:101979. doi: 10.1016/j.arr.2023.101979. Epub 2023 Jun 14.

Natural Products as Bioactive Agents in the Prevention of Dementia

Ullah H, Hussain A, Asif M, Nawaz F, Rasool M.

CNS Neurol Disord Drug Targets. 2023;22(4):466-476. doi: 10.2174/1871527321666220422085835.

Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases

Lo CH, Zeng J.

Transl Neurodegener. 2023 Jun 8;12(1):29. doi: 10.1186/s40035-023-00362-0.

Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging

Martínez-Coria H, Arrieta-Cruz I, Gutiérrez-Juárez R, López-Valdés HE.

Int J Mol Sci. 2023 Feb 21;24(5):4297. doi: 10.3390/ijms24054297.

[Treatment-Quo vadis neurodegeneration?]

Vöglein J, Levin J, Höglinger G.

Nervenarzt. 2023 Oct;94(10):904-912. doi: 10.1007/s00115-023-01544-x. Epub 2023 Oct 6.

Anti-Inflammatory Effect of Traditional Chinese Medicine on the Concept of Mind-Body Interface

Tsai ST, Nithiyanantham S, Satyanarayanan SK, Su KP.

Adv Exp Med Biol. 2023;1411:435-458. doi: 10.1007/978-981-19-7376-5_19.

Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update

Khan SS, Khatik GL, Datusalia AK.

Curr Neuropharmacol. 2023;21(2):309-339. doi: 10.2174/1570159X20666220411083922.

Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways

Phukan BC, Roy R, Gahatraj I, Bhattacharya P, Borah A.

Phytother Res. 2023 Dec;37(12):5657-5699. doi: 10.1002/ptr.8012. Epub 2023 Oct 12.

Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview

Alshial EE, Abdulghaney MI, Wadan AS, Abdellatif MA, Ramadan NE, Suleiman AM, Waheed N, Abdellatif M, Mohammed HS.

Life Sci. 2023 Dec 1;334:122257. doi: 10.1016/j.lfs.2023.122257. Epub 2023 Nov 8.

Glutathione-Mediated Neuroprotective Effect of Purine Derivatives

Matsumura N, Aoyama K.

Int J Mol Sci. 2023 Aug 22;24(17):13067. doi: 10.3390/ijms241713067.

Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges

Kong AH, Wu AJ, Ho OK, Leung MM, Huang AS, Yu Y, Zhang G, Lyu A, Li M, Cheung KH.

Int J Mol Sci. 2023 Jul 22;24(14):11780. doi: 10.3390/ijms241411780.

Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration

Mittal P, Goyal R, Kapoor R, Wan C, Gautam RK.

Curr Neuropharmacol. 2023;21(4):777-786. doi: 10.2174/1570159X21666230220102605.

Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications

Gautam D, Naik UP, Naik MU, Yadav SK, Chaurasia RN, Dash D.

Biomolecules. 2023 Nov 3;13(11):1609. doi: 10.3390/biom13111609.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias